Home / Professional Development / Meetings & Events / American Physiology Summit / Game Changers / Cognitive Decline: Collateral Damage of Cardiometabolic Syndrome

Cognitive Decline: Collateral Damage of Cardiometabolic Syndrome

Saturday, April 6, 2024
8:30–10 a.m.
Room 104BC

This session, chaired by Ann Schreihofer, PhD, FAPS, and Liz Simon, PhD, will discuss how the prevalence of obesity, diabetes and dementia continues to rise—often together—as we age. This session will explore how a Western diet and metabolic syndrome can lead to the development of cognitive decline. Experts will examine cellular, integrative and behavioral mechanisms in animal models and humans, and present findings that could prompt future preventive and counteractive remedies for the loss of cognitive function in people with obesity and metabolic syndrome.

Speakers

GC6 Photo Spkr-Stranahan LgAlexis M. Stranahan, PhD
Medical College of Georgia, Augusta University

Alexis M. Stranahan, PhD, is an associate professor in the Department of Neuroscience and Regenerative Medicine at the Medical College of Georgia. Her research program focuses on neuroimmune regulation of synaptic plasticity in mouse models of obesity, with the goal of elucidating mechanisms for increased rates of cognitive decline among people with obesity.


GC Spkr - Scott Kanoski LgScott Kanoski, PhD
University of Southern California, Los Angeles

Scott Kanoski, PhD, is an associate professor in the Department of Biological Sciences at the University of Southern California’s Dornsife College of Letters, Arts and Sciences. His work is funded by several grants from the National Institutes of Health to study higher-order neural control of food intake, interactions between diet and cognition, and control of feeding by melanin-concentrating hormone.


GC6 Photo Spkr-Feldman LgEva Feldman, MD, PhD
University of Michigan

Eva Feldman, MD, PhD, is the Russell N. DeJong Professor of Neurology at the University of Michigan and director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine. She has also been named the James W. Albers Distinguished University Professor of Neurology. Feldman’s research focuses on neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer's disease and cognitive decline. She also studies the neurologic complications of diabetes and obesity, and how environmental toxins affect the nervous system.


View all Game Changers

Registration

Register Now

 

 

Schedule at a Glance

2024 Summit Schedule at a Glance

Click to Enlarge

Summit Menu

Getting and Staying There
About the Summit
Industry Partners

 

Looking for 2024 Summit Information?